Blackstone Inc
TNYA icon

Blackstone Inc’s Tenaya Therapeutics TNYA Stock Holding History

Blackstone Inc’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-319,655
Closed -$643K – 175
2022
Q4 		$643K Buy
+319,655
New +$780K ﹤0.01% 119

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ROTUOC
Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return

Blackstone Inc's TNYA Position: Q1 2023 in Review

Blackstone Inc sold out of Tenaya Therapeutics (TNYA) in Q1 2023, closing a stake of 319,655 shares — an estimated $643K sold.

Blackstone Inc first reported a position in TNYA in Q4 2022 and held it in 1 quarter. The position peaked at $643K in Q4 2022. 64 funds tracked by Wall St. Rank hold TNYA as of Q1 2023.

  • Blackstone Inc reported no remaining Tenaya Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Blackstone Inc sold 319,655 Tenaya Therapeutics shares in Q1 2023, an estimated $643K.
  • Blackstone Inc first reported a position in Tenaya Therapeutics in Q4 2022 and held it in 1 quarter.
  • Blackstone Inc's Tenaya Therapeutics position peaked at $643K in Q4 2022.
  • 64 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2023.

Based on Blackstone Inc's 13F filing for Q1 2023, filed 15 May 2023.